EP1636176A4 - POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID - Google Patents

POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID

Info

Publication number
EP1636176A4
EP1636176A4 EP04776980A EP04776980A EP1636176A4 EP 1636176 A4 EP1636176 A4 EP 1636176A4 EP 04776980 A EP04776980 A EP 04776980A EP 04776980 A EP04776980 A EP 04776980A EP 1636176 A4 EP1636176 A4 EP 1636176A4
Authority
EP
European Patent Office
Prior art keywords
acetyl
propylphenylthio
propylphenoxy
propoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04776980A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1636176A2 (en
Inventor
Kenneth Walter Locke
David Gregory Roe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicinova Inc
Original Assignee
Medicinova Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicinova Inc filed Critical Medicinova Inc
Publication of EP1636176A2 publication Critical patent/EP1636176A2/en
Publication of EP1636176A4 publication Critical patent/EP1636176A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
EP04776980A 2003-06-24 2004-06-24 POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID Withdrawn EP1636176A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/601,862 US7064146B2 (en) 2003-06-24 2003-06-24 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
PCT/US2004/020154 WO2005000243A2 (en) 2003-06-24 2004-06-24 The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid

Publications (2)

Publication Number Publication Date
EP1636176A2 EP1636176A2 (en) 2006-03-22
EP1636176A4 true EP1636176A4 (en) 2010-03-31

Family

ID=33539463

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04776980A Withdrawn EP1636176A4 (en) 2003-06-24 2004-06-24 POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID

Country Status (11)

Country Link
US (3) US7064146B2 (ja)
EP (1) EP1636176A4 (ja)
JP (2) JP5518280B2 (ja)
KR (1) KR101120408B1 (ja)
CN (1) CN1812968B (ja)
BR (1) BRPI0411973A (ja)
CA (1) CA2530583C (ja)
NO (1) NO20060379L (ja)
NZ (1) NZ544319A (ja)
RU (1) RU2317979C2 (ja)
WO (1) WO2005000243A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060854B2 (en) * 2003-06-24 2006-06-13 Medicinova, Inc. Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
US7064146B2 (en) * 2003-06-24 2006-06-20 Medicinova, Inc. Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
WO2005105073A1 (en) 2004-04-27 2005-11-10 Medicinova, Inc. Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
JP2013119550A (ja) * 2011-12-08 2013-06-17 Medicinova Inc 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法
US8962687B2 (en) 2012-12-05 2015-02-24 Medicinova, Inc. Method of treating liver disorders
CN105407884B (zh) 2013-07-25 2019-04-30 美迪诺亚公司 降低甘油三酯、总胆固醇和低密度脂蛋白血液浓度的方法
US9346754B2 (en) 2014-05-08 2016-05-24 Medicinova, Inc. Method of treating advanced non-alcoholic steatohepatitis
US20150321989A1 (en) * 2014-05-08 2015-11-12 Medicinova, Inc. Method of treating idiopathic pulmonary fibrosis
CA2950909C (en) * 2014-06-02 2023-03-28 Medicinova, Inc. Method of inhibiting or treating fibrosis
CA2955252A1 (en) 2014-08-25 2016-03-03 Aimmune Therapeutics, Inc. Egg protein formulations and methods of manufacture thereof
US20160220710A1 (en) * 2015-01-30 2016-08-04 The Regents Of The University Of Michigan Compositions and methods for delivering pharmaceutical agents
WO2022251464A1 (en) 2021-05-28 2022-12-01 Medicinova, Inc. Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels
JP7478895B1 (ja) 2022-11-30 2024-05-07 花王株式会社 痒みの予防又は改善剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0881412A (ja) * 1994-09-13 1996-03-26 Kyorin Pharmaceut Co Ltd フェノキシアルキルカルボン酸誘導体の製造法
WO2005000242A2 (en) * 2003-06-24 2005-01-06 Medicinova, Inc. Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5858146A (ja) 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US4985585A (en) * 1988-03-07 1991-01-15 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process for their preparations
JPH07116125B2 (ja) * 1988-03-07 1995-12-13 杏林製薬株式会社 フェノキシアルキルカルボン酸誘導体及びその製造法
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
JPH06345682A (ja) * 1993-06-11 1994-12-20 Kyorin Pharmaceut Co Ltd カルボン酸誘導体
US5639475A (en) 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
JPH1179985A (ja) 1997-09-01 1999-03-23 Kyorin Pharmaceut Co Ltd 喘息治療用の粉末吸入剤
US7064146B2 (en) * 2003-06-24 2006-06-20 Medicinova, Inc. Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0881412A (ja) * 1994-09-13 1996-03-26 Kyorin Pharmaceut Co Ltd フェノキシアルキルカルボン酸誘導体の製造法
WO2005000242A2 (en) * 2003-06-24 2005-01-06 Medicinova, Inc. Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, ISBN: 978-3-540-36760-4, DOI: 10.1007/3-540-69178-2_5 *

Also Published As

Publication number Publication date
CA2530583C (en) 2010-08-10
CA2530583A1 (en) 2005-01-06
NO20060379L (no) 2006-03-24
US7365224B2 (en) 2008-04-29
US7728169B2 (en) 2010-06-01
US7064146B2 (en) 2006-06-20
US20060135604A1 (en) 2006-06-22
CN1812968B (zh) 2016-07-27
CN1812968A (zh) 2006-08-02
JP2007524624A (ja) 2007-08-30
EP1636176A2 (en) 2006-03-22
US20040266878A1 (en) 2004-12-30
WO2005000243A2 (en) 2005-01-06
BRPI0411973A (pt) 2006-08-29
RU2317979C2 (ru) 2008-02-27
US20080292698A1 (en) 2008-11-27
JP5518280B2 (ja) 2014-06-11
WO2005000243A3 (en) 2005-04-28
NZ544319A (en) 2008-12-24
RU2006101871A (ru) 2006-07-27
KR101120408B1 (ko) 2012-03-15
KR20060030484A (ko) 2006-04-10
JP2014097989A (ja) 2014-05-29

Similar Documents

Publication Publication Date Title
IL209966A0 (en) Modafinil polymorphic forms
GB0202216D0 (en) Novel compounds
GB0225944D0 (en) Novel compounds
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
GB0202679D0 (en) Novel compounds
IL164645A0 (en) Polymorph of 4-Ä2-Ä1-(2-ethoxyethyl)-1H-benzidimazole-2-YLÜ-1-piperidinylÜethylÜ-??-dimethyl-benzenoacetic acid
EP1636176A4 (en) POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID
AU2003209667A8 (en) Bicalutamide polymorphs
HK1086549A1 (en) Method for the production of a thioacetic acid andsalts thereof
AU2003276026A1 (en) Bicalutamide forms
EP1701936A4 (en) EFFICIENT METHOD FOR PREPARING THE POLYMORPHOS FORM A FROM (E) -ENTACAPONE
PL378119A1 (pl) Kwasy karboksylowe
GB0313677D0 (en) Novel compound
AU2003251523A8 (en) Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
PL1656340T3 (pl) Sposoby wytwarzania pochodnych kwasu 1-karbamoilocykloalkilokarboksylowego
GB0200025D0 (en) Novel compounds
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether
GB0327738D0 (en) Novel compound
SI1667975T1 (sl) Polimorfna oblika 3-fenilsulfonil-8-piperazin-1-il-kinolina
IL172699A0 (en) Novel fusidic acid derivatives
GB0315592D0 (en) Shoelace gripper
GB0328752D0 (en) Anti-inflammatory compounds
GB0301397D0 (en) Tab tape
GB0201794D0 (en) Pharmaceutically-useful compounds
GB0202219D0 (en) Novel compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051220

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100302

RTI1 Title (correction)

Free format text: THE POLYMORPHIC FORM A OF 4-( 6-ACETYL-3-(3-(4-ACETYL-3- HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY)-2-PROPYLPHENOXY) BUTRYRIC ACID

17Q First examination report despatched

Effective date: 20111125

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131107